Two webb blogs, Biomedsreport and Biotech Stocks - Chasing the Alpha stated that this would be in the $6.00 or more after the FDA clearance.
It spiked a little and ever since had dropped close to its book value.
Just on the Government contract alone it should be in the $2.50-$3.00 range.
$6.00????, No Chance!!!!!
$$M, Some Rounding
There is approx 60 Cents of Book Value and 60 Cents of Revenue, that is the value.....
44M of intangible assets; 96 cents per share of nothing...&...17M or 36.22 Cents of cash Yoy; Not Included;
$1.20.....There is no urgency here; except possibly to sell this thing.
Desc, Breakdown, Price: , Metric , Weight , Primary Weight Adj Trading Metric , Weight Adj Price
20.Net Income or Loss: , PTInc.St. 1.35 , (23) , 1.81 , (42.251) ,9-2010 2.44
21.Std Value , PtStdVal/Rev:, 1.35 , 0.27 , 1.26 , 0.34 , 1.70
22.Balance Sheet: , PTNetBSFlexFactor: 1.35 , 2.04 , 1.21 , 1.21 , 1.63
23.Discretionary Cash Per CF: , PT Discret. CashApprox[1M]: 1.35 , 32.7 , 1.08 , 35 , 1.46
24.Ownership Equity Metric: , PT OE : 1.35 , (13.09) (0.94) 12.36 ,Low, (1.28)
Sum Trading At: ,Metric, (1.42_70) ,Weight, 4.41 ,Primary Weight Adj Trade Metric, 7 , (0.46)cents off adjusted high of $1.80_9.
Net $$M : (2.657)
Estimated Local Continuing Value in $$M / (7.82)
Estimated Factor NotLocal in $$M: (12.546_122_612)
Estimated ContinuingValueNotLocal in $$M: 98
EstNotLocalprice on Fwd Value: 0.75
2.12, Factor Forward.
0.36, Price To.
CF,NTA,REV,Equity: Adjusted, 69M, 1.5/ Per Share
CF,NTA, Rev, Equity Further Adj to Approx MMC.: $$M 57M, 1.22 Per Share.
The Desired Lowest / Minimum 55M Market Cap Price; ,
The Accum Deficit (85M) per 46M Shares O/S;Not Local Sports Event Price, 98MFwd:
[12b.], 0.75, (0.44), (37%)
Price to Sched Amts @, 0.75 ,
Estimated Fwd: 98M
[36.d.], 98M, 2.12 Per Share & Fwd PriceTo 0.36
USD:LBP 1,502.5, LBP:USD .000665_557
[42.1224e.], (12) $$M , Per Share:, (0.26)
[52f.], PriceTo:, (4.59)
[58g.]:Market Cap Over Minimum: 7.42, 0.16 , Per Share: PriceTo, 7.36
[77i.] ,Share Price Drop MiLB, , 2.25 1.45 , Per Share: PriceTo, (36%)
[82j.] Equity:Common, Auth:85M Shares Auth. Per Avg Shares O/S 0.46, 0.01 $$M,Value, PriceTo:, 119.136
[98j.] Primary Co Metric;61,Weighted Adjusted Price; 0.77;Weighted Adjusted Trade Metric; 0.67_5
[99k.] ,Per Desired Spread : MMC Price & Weighted Price, ,+Trading @ Plus, 0.42 ,-Minus, (0.07)
[112. @ the Current Bid of.], 1.35 ,+Trading @ Premium to MMC, 0.16 ,+Plus, 14.36%
I do not like price to sales @ 2.31; but i like fwd activity / sales @ 2.12 per share and .36 Price to.....Much cleaner and efficient.....
Profile:iCAD, Inc. provides image analysis and workflow solutions that enable radiologists and other healthcare professionals to identify pathologies and pinpoint cancer earlier.
In addition the .61 per ttm sales @ 75 Cents is 1.22 Price to Sales....
JOD:CHF = 1.39_55
CHF:JOD = .72
I got about 300 shares at 2 and change, and since i only invested about 650 dollars, I will either hold it make out some nice profit being patient,or i will ride it down to practically nothing and use it as a minimal write off. The best thing right now is too just go away and come back and check it a few months. Watching it daily is a waste of time.
You must be experiencing severe memory problems...recall this little move where ICAD management stuck a pin in the stock price?
:.....Elsewhere, iCAD (ICAD_) said in a regulatory filing Friday that it will offer $75 million in common stock. Net proceeds will be used to make acquisitions of assets, businesses or securities, to repay debt or capital expenditures, or for working capital. .."
Taking into account that the ICAD market cap is about $75M, this is a major dilution. ICAD management has effectively killed this stock.